| Authors: |
Bunick CG; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA; Program in Translational Biomedicine, Yale School of Medicine, New Haven, Connecticut, USA., Armstrong AW; Department of Dermatology, University of California Los Angeles, Los Angeles, California, USA., Grada A; AbbVie, North Chicago, Illinois, USA., Soliman AM; AbbVie, North Chicago, Illinois, USA., Li C; AbbVie, North Chicago, Illinois, USA., Bristow CC; AbbVie, North Chicago, Illinois, USA., Khan IA; AbbVie, North Chicago, Illinois, USA., Lipiszko D; AbbVie, North Chicago, Illinois, USA., Silverberg JI; Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA., Issa NT; Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA; Issa Research and Consulting, Springfield, Virginia, USA; Forefront Dermatology, Vienna, Virginia, USA; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA., Mostaghimi A; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA. Electronic address: amostaghimi@bwh.harvard.edu. |